Proteomics profiling of end-stage COVID-19 diseased human lungs

ABSTRACT: Lung biopsies were collected from recently deceased patients, who tested positive and were treated for SARS-CoV-2 infections, or from patients that succumbed to a non-inflammatory unrelated disease, serving as control. Two samples were taken from each patient either from macroscopically affected lung tissue, for SARS-CoV-2 patients, or healthy homogeneous lung parenchyma of the control patients. All samples were then subjected to shotgun proteomics analysis using data independent acquisition approach.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung

DISEASE(S): Severe Covid-19

SUBMITTER: Tamara Tomin  

LAB HEAD: Ruth Birner-Gruenberger

PROVIDER: PXD030009 | Pride | 2023-03-08

REPOSITORIES: Pride